Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

Condition:   Infections, Cytomegalovirus Intervention:   Drug: Letermovir 240 mg Oral Tablet Sponsors:   Maimónides Biomedical Research Institute of Córdoba;   MERCK SHARP & DOHME DE ESPAÑA S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials